HOXA13 serves as a biomarker to predict neoadjuvant therapy efficacy in advanced colorectal cancer patients
Liu, Shuanghui, Zhang, Rui, Yang, Zhengquan, Wang, Yajiao, Guo, Xingxiu, Zhao, Youjuan, Lin, Huangjue, Xiang, Youqun, Ding, Chunming, Dong, Zhixiong, Xu, Chang
Published in Acta biochimica et biophysica Sinica (01.02.2023)
Published in Acta biochimica et biophysica Sinica (01.02.2023)
Get full text
Journal Article
HOXA13 serves as a biomarker to predict neoadjuvant therapy efficacy in advanced colorectal cancer patients: HOXA13 predicts neoadjuvant therapy efficacy of CRC
Liu, Shuanghui, Zhang, Rui, Yang, Zhengquan, Wang, Yajiao, Guo, Xingxiu, Zhao, Youjuan, Lin, Huangjue, Xiang, Youqun, Ding, Chunming, Dong, Zhixiong, Xu, Chang
Published in Acta biochimica et biophysica Sinica (12.12.2022)
Published in Acta biochimica et biophysica Sinica (12.12.2022)
Get full text
Journal Article